Pacific Edge Investor Relations Material
Latest events
H1 2025
Pacific Edge
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pacific Edge Limited
Access all reports
Pacific Edge Limited is a New Zealand-based biotechnology company specializing in the development of diagnostic tools for cancer detection and management. The company’s primary focus is on non-invasive diagnostic tests for urological cancers, particularly bladder cancer. Pacific Edge’s tests utilize molecular technology to aid in early cancer detection, monitoring, and management, providing alternative solutions to traditional diagnostic methods. These tools are designed for use in clinical and laboratory settings. The company is headquartered in Dunedin, New Zealand, and its shares are listed on the NZX.
Key slides for Pacific Edge Limited
AGM 2024
Pacific Edge Limited
H1 2025
Pacific Edge Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PEB
Country
🇳🇿 New Zealand